Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Receivables (2020 - 2025)

Historic Receivables for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to $5.6 million.

  • Rapid Micro Biosystems' Receivables rose 4047.38% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year increase of 4047.38%. This contributed to the annual value of $7.6 million for FY2024, which is 3528.05% up from last year.
  • As of Q3 2025, Rapid Micro Biosystems' Receivables stood at $5.6 million, which was up 4047.38% from $6.1 million recorded in Q2 2025.
  • In the past 5 years, Rapid Micro Biosystems' Receivables registered a high of $7.6 million during Q4 2024, and its lowest value of $3.8 million during Q2 2023.
  • Moreover, its 5-year median value for Receivables was $5.2 million (2024), whereas its average is $5.1 million.
  • Its Receivables has fluctuated over the past 5 years, first crashed by 2162.74% in 2022, then skyrocketed by 4300.28% in 2023.
  • Over the past 5 years, Rapid Micro Biosystems' Receivables (Quarter) stood at $5.4 million in 2021, then grew by 1.26% to $5.5 million in 2022, then increased by 2.98% to $5.6 million in 2023, then soared by 35.28% to $7.6 million in 2024, then fell by 26.84% to $5.6 million in 2025.
  • Its last three reported values are $5.6 million in Q3 2025, $6.1 million for Q2 2025, and $4.6 million during Q1 2025.